Immetas Therapeutics Announces Series A Financing to Advance Research on Inflammation Pathways in Aging and Develop Therapeutics for Cancer and Inflammatory Disease
East Hanover, NJ – September 23, 2020 – Immetas Therapeutics today announced it has raised a Series A financing of $11 million to advance research on inflammation pathways in